{"id":12391,"date":"2022-02-23T08:17:49","date_gmt":"2022-02-23T08:17:49","guid":{"rendered":"https:\/\/fibrosisquistica.org\/?p=12391"},"modified":"2022-02-23T08:17:49","modified_gmt":"2022-02-23T08:17:49","slug":"boletin-informativo-sobre-el-proyecto-de-investigacion-hit-cf-europe-febrero-2022","status":"publish","type":"post","link":"https:\/\/fibrosisquistica.org\/en\/boletin-informativo-sobre-el-proyecto-de-investigacion-hit-cf-europe-febrero-2022\/","title":{"rendered":"Bolet\u00edn informativo sobre el proyecto de investigaci\u00f3n HIT-CF Europe \u2013 Febrero 2022"},"content":{"rendered":"<p><strong>La Asociaci\u00f3n Europea de Fibrosis Qu\u00edstica (CF Europe) ha publicado su bolet\u00edn informativo de febrero 2022 sobre la evoluci\u00f3n del proyecto de investigaci\u00f3n HIT-CF Europe.<\/strong><\/p>\n<p>Este proyecto tiene como objetivo evaluar la eficacia y seguridad de diferentes f\u00e1rmacos (moduladores CFTR y otros) en pacientes con FQ y mutaciones raras basadas en la respuesta de organoides intestinales.<\/p>\n<p>A continuaci\u00f3n, os dejamos el bolet\u00edn traducido al espa\u00f1ol y en formato PDF para descargar con los links activos: <a href=\"https:\/\/fibrosisquistica.org\/wp-content\/uploads\/2022\/02\/HIT-CF-Newsletter-February-2022_espanol.pdf\">HIT-CF Newsletter Febrero 2022 espa\u00f1ol<\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-large wp-image-12393\" src=\"https:\/\/fibrosisquistica.org\/wp-content\/uploads\/2022\/02\/HIT-CF-Newsletter-February-2022_espanol-1-709x1024.jpg\" alt=\"\" width=\"709\" height=\"1024\" title=\"\" srcset=\"https:\/\/fibrosisquistica.org\/wp-content\/uploads\/2022\/02\/HIT-CF-Newsletter-February-2022_espanol-1-709x1024.jpg 709w, https:\/\/fibrosisquistica.org\/wp-content\/uploads\/2022\/02\/HIT-CF-Newsletter-February-2022_espanol-1-scaled-600x867.jpg 600w, https:\/\/fibrosisquistica.org\/wp-content\/uploads\/2022\/02\/HIT-CF-Newsletter-February-2022_espanol-1-208x300.jpg 208w, https:\/\/fibrosisquistica.org\/wp-content\/uploads\/2022\/02\/HIT-CF-Newsletter-February-2022_espanol-1-768x1109.jpg 768w, https:\/\/fibrosisquistica.org\/wp-content\/uploads\/2022\/02\/HIT-CF-Newsletter-February-2022_espanol-1-1063x1536.jpg 1063w, https:\/\/fibrosisquistica.org\/wp-content\/uploads\/2022\/02\/HIT-CF-Newsletter-February-2022_espanol-1-1418x2048.jpg 1418w, https:\/\/fibrosisquistica.org\/wp-content\/uploads\/2022\/02\/HIT-CF-Newsletter-February-2022_espanol-1-scaled.jpg 1772w\" sizes=\"auto, (max-width: 709px) 100vw, 709px\" \/><\/p>\n<p><strong><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-large wp-image-12394\" src=\"https:\/\/fibrosisquistica.org\/wp-content\/uploads\/2022\/02\/HIT-CF-Newsletter-February-2022_espanol-2-709x1024.jpg\" alt=\"\" width=\"709\" height=\"1024\" title=\"\" srcset=\"https:\/\/fibrosisquistica.org\/wp-content\/uploads\/2022\/02\/HIT-CF-Newsletter-February-2022_espanol-2-709x1024.jpg 709w, https:\/\/fibrosisquistica.org\/wp-content\/uploads\/2022\/02\/HIT-CF-Newsletter-February-2022_espanol-2-scaled-600x867.jpg 600w, https:\/\/fibrosisquistica.org\/wp-content\/uploads\/2022\/02\/HIT-CF-Newsletter-February-2022_espanol-2-208x300.jpg 208w, https:\/\/fibrosisquistica.org\/wp-content\/uploads\/2022\/02\/HIT-CF-Newsletter-February-2022_espanol-2-768x1109.jpg 768w, https:\/\/fibrosisquistica.org\/wp-content\/uploads\/2022\/02\/HIT-CF-Newsletter-February-2022_espanol-2-1063x1536.jpg 1063w, https:\/\/fibrosisquistica.org\/wp-content\/uploads\/2022\/02\/HIT-CF-Newsletter-February-2022_espanol-2-1418x2048.jpg 1418w, https:\/\/fibrosisquistica.org\/wp-content\/uploads\/2022\/02\/HIT-CF-Newsletter-February-2022_espanol-2-scaled.jpg 1772w\" sizes=\"auto, (max-width: 709px) 100vw, 709px\" \/><\/strong><\/p>\n<p><strong>M\u00e1s informaci\u00f3n en la web <\/strong><a href=\"https:\/\/www.hitcf.org\/\" rel=\"nofollow noopener\" target=\"_blank\"><strong style=\"font-style: inherit;\">www.hitcf.org<\/strong><\/a><\/p>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>La Asociaci\u00f3n Europea de Fibrosis&#8230;<\/p>","protected":false},"author":22,"featured_media":12395,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[64],"tags":[],"class_list":{"0":"post-12391","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-investigacion"},"acf":[],"_links":{"self":[{"href":"https:\/\/fibrosisquistica.org\/en\/wp-json\/wp\/v2\/posts\/12391","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fibrosisquistica.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fibrosisquistica.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fibrosisquistica.org\/en\/wp-json\/wp\/v2\/users\/22"}],"replies":[{"embeddable":true,"href":"https:\/\/fibrosisquistica.org\/en\/wp-json\/wp\/v2\/comments?post=12391"}],"version-history":[{"count":1,"href":"https:\/\/fibrosisquistica.org\/en\/wp-json\/wp\/v2\/posts\/12391\/revisions"}],"predecessor-version":[{"id":12396,"href":"https:\/\/fibrosisquistica.org\/en\/wp-json\/wp\/v2\/posts\/12391\/revisions\/12396"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fibrosisquistica.org\/en\/wp-json\/wp\/v2\/media\/12395"}],"wp:attachment":[{"href":"https:\/\/fibrosisquistica.org\/en\/wp-json\/wp\/v2\/media?parent=12391"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fibrosisquistica.org\/en\/wp-json\/wp\/v2\/categories?post=12391"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fibrosisquistica.org\/en\/wp-json\/wp\/v2\/tags?post=12391"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}